Singapore, Nov. 19 -- Japan-based Takeda and Singapore's Zuellig Pharma have announced a strategic regional collaboration to enhance sustainable patient access to innovative medicines and healthcare solutions across Malaysia, Indonesia and the Philippines.

Effective December 1, 2026, the collaboration will bring together selected products from Takeda's innovative portfolio with Zuellig Pharma's extensive regional network, commercial capabilities and deep local market expertise, to strengthen sustainable access to medicines and improve health outcomes across the region.

Building on the long-standing relationship between the two companies, the collaboration combines complementary capabilities to support patients, healthcare professionals ...